CRLS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.51470005613919E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.1540994522602E-10 |
Normal-vs-Stage2 |
1.42930000002206E-06 |
Normal-vs-Stage3 |
3.75930000018343E-07 |
Normal-vs-Stage4 |
1.94095999999089E-05 |
Stage1-vs-Stage2 |
8.503600E-01 |
Stage1-vs-Stage3 |
9.262400E-01 |
Stage1-vs-Stage4 |
2.242200E-01 |
Stage2-vs-Stage3 |
9.304800E-01 |
Stage2-vs-Stage4 |
4.278000E-01 |
Stage3-vs-Stage4 |
3.571400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.51370085541703E-11 |
Normal-vs-AfricanAmerican |
5.70690000034624E-07 |
Normal-vs-Asian |
4.151600E-01 |
Caucasian-vs-AfricanAmerican |
6.752200E-01 |
Caucasian-vs-Asian |
4.875000E-01 |
AfricanAmerican-vs-Asian |
6.474600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.54709997538072E-09 |
Normal-vs-Female |
5.77309977600748E-10 |
Male-vs-Female |
1.746800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.851400E-01 |
Normal-vs-Age(41-60Yrs) |
1.85759996274015E-09 |
Normal-vs-Age(61-80Yrs) |
4.24350554695252E-11 |
Normal-vs-Age(81-100Yrs) |
3.53080009674045E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.189600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.378000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.179800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.904400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.798100E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.185600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.62481139653892E-12 |
Normal-vs-Grade 2 |
2.96259999865711E-08 |
Normal-vs-Grade 3 |
1.33780000410866E-08 |
Normal-vs-Grade 4 |
4.7568999850256E-09 |
Grade 1-vs-Grade 2 |
3.79110000000571E-05 |
Grade 1-vs-Grade 3 |
1.817720E-04 |
Grade 1-vs-Grade 4 |
5.033400E-04 |
Grade 2-vs-Grade 3 |
7.730200E-01 |
Grade 2-vs-Grade 4 |
5.865200E-01 |
Grade 3-vs-Grade 4 |
8.047800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62447832963153E-12 |
Normal-vs-ccB subtype |
4.177200E-04 |
ccA subtype-vs-ccB subtype |
1.51959999999951E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.4603000000335E-06 |
Normal-vs-N1 |
3.048500E-02 |
N0-vs-N1 |
3.404800E-01 |
|
|